ArticleVeterinary research communications2025
Effects of dietary supplementation of Macleaya cordata extract on inflammatory and oxidative status, liver function and milk yield in dairy cattle during the transition period.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Immune function and oxidative stress are crucial during the transition period (TP) in dairy cattle, influencing their metabolic adaptation to the new lactation. The supplementation with Macleaya cordata, an herb known for its anti-inflammatory, antibacterial, and antioxidant properties, may influence these processes. This study aimed to evaluate the effects of Macleaya cordata extract (MCE) on inflammatory and oxidative status and liver function during the TP, as well as on subsequent early lactation. On day 24 (± 3) before the expected calving date, sixty-four cows were randomly assigned to two groups: the MCE group (MCEG), which received a controlled-release oral bolus delivering 1.5 g of MCE daily for 70 days, and the control group (CG), in which bolus placement was simulated using a balling gun. Blood samples were collected at three time points: 24 days before calving, 7 and 21 days postpartum. Biomarkers of oxidative status, inflammation, energy balance and liver function were measured in plasma samples. A significant interaction effect (supplementation × time) was observed for milk yield (P < 0.05), with higher values in MCEG (51.3 ± 1.1 kg/day) than in CG (46.5 ± 1.1 kg/day) on days 25 postpartum. No significant differences were observed in body condition score, non-esterified fatty acids and beta-hydroxybutyrate concentrations. However, an interaction effect was observed for glucose concentrations (P < 0.05), with higher values in the MCEG on day 7 postpartum. Liver function biomarkers showed no significant differences between groups. Plasma 3-nitrotyrosine and serum interleukin-1 concentrations were lower in the MCEG (P < 0.05). These findings suggest that MCE supplementation may enhance milk production, potentially associated, among other mechanisms, with improvements in inflammatory and oxidative status in dairy cows.
Indexed as
Identifiers
41317279What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.